Diagnosis
What are the most important prognostic factors to consider in AML?
Published on December 5, 2018 in Diagnosis
How likely is it for patients with MDS to transform to AML?
Published on November 7, 2018 in Diagnosis
What are the practical issues in FLT3 testing as it relates to PCR vs. NGS?
Published on October 10, 2018 in Diagnosis
What are the latest guidelines for molecular testing in AML?
Published on July 24, 2018 in Diagnosis
Do I need to re-test patients at relapse who had an IDH mutation at diagnosis?
Published on May 2, 2018 in Diagnosis
53-year-old woman presenting with severe fatigue and bruising
Published on March 21, 2018 in Diagnosis
Molecular Abnormalities in AML
Published on March 21, 2018 in Diagnosis
The hematopathologist's role in the diagnosis of AML
Published on December 26, 2017 in Diagnosis
Recommended baseline cytogenetic molecular & immune profiling workup in newly diagnosed AML patients
Published on May 31, 2017 in Diagnosis
Is molecular testing standard/routine for patients diagnosed with AML in the community setting?
Published on May 31, 2017 in Diagnosis
Page 1 of 2
Results 1 - 10 of 13